Position in QURE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,381,866
-$2,777,285 QoQ
Shares Held
206,842
-19.6% QoQ
Ownership
0.328%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QURE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Parkman Healthcare Partners LLC holds $362,342,788 across 36 Biotechnology names. QURE ranks #30 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KALV |
KalVista Pharmaceuticals, Inc.
|
1,835,506 | $36,948,735 | |
| 2 | PTCT |
Ptc Therapeutics, Inc.
|
431,364 | $29,388,829 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
497,035 | $28,902,585 | |
| 4 | RCUS |
Arcus Biosciences, Inc.
|
1,207,274 | $26,077,118 | |
| 5 | MBX |
MBX Biosciences, Inc.
|
800,037 | $23,881,104 | |
| 6 | SNDX |
Syndax Pharmaceuticals Inc
|
901,511 | $21,059,296 | |
| 7 | EYPT |
EyePoint, Inc.
|
1,354,800 | $17,463,372 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
403,525 | $13,651,250 |
All Filings in QURE
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,381,866 | 206,842 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,159,151 | 257,382 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $20,158,429 | 345,356 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,181,302 | 443,422 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,160,629 | 203,833 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,856,500 | 275,000 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||